polyclonal antibody (Proteintech)
Proteintech is a verified supplier 
93
Structured Review
Proteintech
polyclonal antibody
Polyclonal Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 8 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ccr2b/CCR2b-specific+Antibody/pmc12591211-373-17-19
Average 93 stars, based on 8 article reviews
Polyclonal Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 8 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ccr2b/CCR2b-specific+Antibody/pmc12591211-373-17-19
Average 93 stars, based on 8 article reviews
polyclonal antibody - by Bioz Stars,
2026-09
93/100 stars
Images
Related Articles
Incubation:Article Title: Combination therapy with bevacizumab and a CCR2 inhibitor for human ovarian cancer: An in vivo validation study. Article Snippet: .. Slides were incubated with primary antibodies against CD31 (1:1000 dilution, Cat# 11265- 1- AP, RRID:AB_2299349; Proteintech), CCR2A (1:200 dilution, Cat# 16153- 1- AP, RRID:AB_2262945; Proteintech), and Article Title: Inducing Receptor Degradation as a Novel Approach to Target CC Chemokine Receptor 2 (CCR2) Article Snippet: Cells were then washed three times in PBS and simultaneously permeabilized and blocked for an hour using a modified blocking buffer (0.1% Triton ( v / v ), 1% BSA ( w / v ) (Sigma, A7030, Merck, Darmstadt, Germany)). .. Primary antibodies were diluted to 1:500 ( Article Title: Combination therapy with bevacizumab and CCR2 inhibitor for women with ovarian cancer: in vivo validation study Article Snippet: .. They were then incubated with primary antibodies against CCR2A (1:1 000 dilution, Proteintech Cat# 16153-1-AP, RRID:AB_2262945), and Article Title: Combination therapy with bevacizumab and a CCR2 inhibitor for human ovarian cancer: An in vivo validation study Article Snippet: .. Slides were incubated with primary antibodies against CD31 (1:1000 dilution, Cat# 11265‐1‐AP, RRID:AB_2299349; Proteintech), CCR2A (1:200 dilution, Cat# 16153‐1‐AP, RRID:AB_2262945; Proteintech), and Saline:Article Title: Combination therapy with bevacizumab and a CCR2 inhibitor for human ovarian cancer: An in vivo validation study Article Snippet: SDS‐polyacrylamide gel electrophoresis (PAGE), which separated proteins using a 15% SDS sulfate‐polyacrylamide gel, was used to transfer the proteins to PVDF membranes (Millipore, Billerica, MA, USA). .. Membranes were blocked in 5% non‐fat dry milk in TBS‐T buffer (0.1% Tween‐20 in Tris‐buffered saline) for 1 h at room temperature and then exposed to primary antibodies against CCR2A (1:1000 dilution, Cat# 16153‐1‐AP, RRID:AB_2262945; Proteintech), and Article Title: Combination therapy with bevacizumab and a CCR2 inhibitor for human ovarian cancer: An in vivo validation study. Article Snippet: SDS- polyacrylamide gel electrophoresis (PAGE), which separated proteins using a 15% SDS sulfate- polyacrylamide gel, was used to transfer the proteins to PVDF membranes (Millipore, Billerica, MA, USA). .. Membranes were blocked in 5% non- fat dry milk in TBS- T buffer (0.1% Tween- 20 in Tris- buffered saline) for 1 h at room temperature and then exposed to primary antibodies against CCR2A (1:1000 dilution, Cat# 16153- 1- AP, RRID:AB_2262945; Proteintech), and |
